Spots Global Cancer Trial Database for Oxaliplatin for Children With Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Oxaliplatin for Children With Solid Tumors
Official Title: Phase II Study With Oxaliplatin In Children With Relapsed/Refractory Solid Tumors
Study ID: NCT01558453
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the pediatric neoplastic response to chemotherapy proposed and evaluate sensitivity to oxaliplatin through immunohistochemistry ERCC-1 expression analysis.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Santa Marcelina Hospital, Sao Paulo, SP, Brazil
Contact Details
Name: Sidnei Epelman, MD
Affiliation: Santa Marcelina Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
